Overview
Gi Min practices in Seoul, Republic of Korea. Ms. Min is rated as an Advanced expert by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). Her top areas of expertise are Hepatic Venoocclusive Disease with Immunodeficiency, Leukemia, Acute Lymphoblastic Leukemia (ALL), Bone Marrow Transplant, and Splenectomy.
Her clinical research consists of co-authoring 54 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 14 articles in the study of Acute Lymphoblastic Leukemia (ALL).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Acute Lymphoblastic Leukemia (ALL)
- Bone Marrow TransplantMs. Min isAdvanced. Learn about Bone Marrow Transplant.
- Febrile NeutropeniaMs. Min isAdvanced. Learn about Febrile Neutropenia.
- Hepatic Venoocclusive Disease with Immunodeficiency
- LeukemiaMs. Min isAdvanced. Learn about Leukemia.
- Experienced
- Acute Myeloid Leukemia (AML)Ms. Min isExperienced. Learn about Acute Myeloid Leukemia (AML).
- AnemiaMs. Min isExperienced. Learn about Anemia.
- Aplastic AnemiaMs. Min isExperienced. Learn about Aplastic Anemia.
- AscitesMs. Min isExperienced. Learn about Ascites.
- Chronic Familial NeutropeniaMs. Min isExperienced. Learn about Chronic Familial Neutropenia.
- Graft Versus Host Disease (GvHD)Ms. Min isExperienced. Learn about Graft Versus Host Disease (GvHD).